Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 17 Projects
Project # Contact PI Funding Organization Fiscal Year
Multiple nuclear receptor activation in the treatment of Alzheimer’s disease
#18024CB Dieter Lütjohann Alzheimer Forschung Initiative e. V. 2018
SUMO2 mimetics as innovative Inhibitors of Tau toxicity in Pre-clinical Models of Frontotemporal Dementia
GA-201807-2015738 Fioriti, Luana Alzheimer's Drug Discovery Foundation 2018
Repurposing lenalidomide for early Alzheimer's treatment
GC-2013717 Sabbagh, Marwan Alzheimer's Drug Discovery Foundation 2018
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
Evaluation and development of optimized PDI modulators for AD
GC-2013823 Stockwell, Brent Alzheimer's Drug Discovery Foundation 2018
Effect of early supplementation with high dose DHA on cognitive outcomes in APOE4 carriers: "PreventE4 Trial"
GC-201711-2014197 Yassine, Hussein Alzheimer's Drug Discovery Foundation 2018
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
A pilot pharmacodynamic study of Anti-SEMA4D Antibody (VX15) in early Alzheimer’s disease
GC-201801-2014580 Siemers, Eric Alzheimer's Drug Discovery Foundation 2018
Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease
GC-201801-2014589 Van Eldik, Linda Alzheimer's Drug Discovery Foundation 2018
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018